497 1 d611816d497.htm FORM 497 Form 497

iShares®

iShares Trust

Supplement dated December 19, 2023 (the “Supplement”)

to the currently effective Summary Prospectus, Prospectus

and Statement of Additional Information (“SAI”)

for each of the funds listed below (each, a “Fund”)

The information in this Supplement updates information in, and should be read in conjunction with, the Summary Prospectus, Prospectus and SAI for each Fund.

The Board of Trustees of iShares Trust has authorized the following stock split for each Fund at the ratios indicated below. The Creation Unit size for each Fund will remain at 50,000 shares per unit.

 

     
Fund Name   Ticker   Proposed Forward Split Ratio
     

iShares Expanded Tech Sector ETF

  IGM  

6:1

     

iShares Expanded Tech-Software Sector ETF

  IGV  

5:1

     

iShares U.S. Pharmaceuticals ETF

  IHE  

3:1

     

iShares U.S. Healthcare Providers ETF

  IHF  

5:1

     

iShares Core S&P Mid-Cap ETF

  IJH  

5:1

     

iShares U.S. Financial Services ETF

  IYG  

3:1

     

iShares U.S. Healthcare ETF

  IYH  

5:1

     

iShares U.S. Consumer Staples ETF

  IYK  

3:1

     

iShares U.S. Transportation ETF

  IYT  

4:1

     

iShares Semiconductor ETF

  SOXX  

3:1

For the iShares Core S&P Mid-Cap ETF, the record date for the stock split will be February 16, 2024, and the stock split will be effectuated after the close of trading on February 21, 2024. Shares of the iShares Core S&P Mid-Cap ETF will begin trading on a split-adjusted basis on February 22, 2024.

For each Fund other than the iShares Core S&P Mid-Cap ETF, the record date for the stock split will be March 4, 2024, and the stock split will be effectuated after the close of trading on March 6, 2024. Shares of each Fund other than the iShares Core S&P Mid-Cap ETF will begin trading on a split-adjusted basis on March 7, 2024.

If you have any questions, please call 1-800-iShares (1-800-474-2737).

 

iShares® is a registered trademark of BlackRock Fund Advisors and its affiliates.

IS-A-FS-1223

 

 

 

PLEASE RETAIN THIS SUPPLEMENT

FOR FUTURE REFERENCE